ARTICLE | Financial News
Aldexa Therapeutics proposes IPO
January 13, 2014 8:00 AM UTC
Aldexa Therapeutics Inc., Burlington, Mass. Business: Autoimmune, Ophthalmic Date announced: 1/6/14 Type: IPO To be raised: Up to $20.8 million Shares: TBD Price: TBD Underwriter: Aegis Capital Note: ...